Stay updated with breaking news from Jason Thonhoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This investigator-initiated, double-blind, placebo-controlled study evaluates the safety and tolerability, biological activity, and preliminary efficacy of LD IL-2 in 38 patients with...
Serum 4-Hydroxynonenal levels are significantly increased in ALS patients- the higher the 4-HNE level, the faster the progression and shorter the survival; Serum 4-HNE levels are increased in...
4-Hydroxynonenal levels strongly correlate with rate of Amyotrophic Lateral Sclerosis disease progression and survival of patients from onset and diagnosis to death 4-HNE levels may serve as a...
Coya’s Scientific Board Chairman Dr. Stanley Appel and Chief Medical Officer Dr. Fred Grossman to participate in discussion hosted by BTIG Analyst Tom Shrader ...
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Alireza Faridar, the Stanley H. Appel Chair in Translational...